AGIOS PHARMACEUTICALS, INC. Income Statement
AGIO / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
AGIOS PHARMACEUTICALS, INC. reported $54M in revenue and $413M in net loss for FY2025. Revenue has grown at a 6.7% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54.0M | $36.5M | $26.8M | $14.2M | $0 | $0 | $117.9M | $94.4M | $10.5M | $69.9M | $34.2M | $8.4M | $25.5M | $25.1M | $21.8M |
| Cost of Revenue | $6.3M | $4.2M | $2.9M | $1.7M | $0 | $0 | $1.3M | $1.4M | $0 | $0 | - | - | - | - | - |
| SG&A Expense | $180.3M | $156.8M | $119.9M | $121.7M | $121.4M | $115.1M | $102.0M | $114.1M | $71.1M | $50.7M | $9.9M | $19.1M | $9.9M | $7.1M | $7.2M |
| R&D Expense | $339.5M | $301.3M | $295.5M | $279.9M | $257.0M | $220.8M | $214.3M | $341.3M | $292.7M | $220.2M | $54.5M | $100.4M | $54.5M | $41.0M | $31.3M |
| Operating Income | -$472.1M | -$425.7M | -$391.5M | -$389.0M | -$378.4M | -$335.9M | -$316.3M | -$362.5M | -$320.8M | -$201.0M | -$38.9M | -$54.1M | -$38.9M | -$23.0M | -$16.6M |
| Income Tax | -$1.0M | $44.2M | $0 | $0 | - | - | $0 | $0 | $0 | $0 | $579.0K | -$426.0K | $579.0K | -$2.8M | $7.2M |
| Net Income | -$412.8M | $673.7M | -$352.1M | -$231.8M | $1.6B | -$327.4M | -$411.5M | -$346.0M | -$314.7M | -$198.5M | -$39.4M | -$53.5M | -$39.4M | -$20.1M | -$23.7M |
| EPS (Basic) | -$7.12 | $11.86 | -$6.33 | -$4.23 | $26.55 | -$4.74 | -$6.86 | - | - | - | - | -$0.39 | - | - | - |
| EPS (Diluted) | -$7.12 | $11.64 | -$6.33 | -$4.23 | $26.55 | -$4.74 | -$6.86 | -$6.03 | -$3.15 | -$5.07 | -$2.83 | -$0.39 | -$8.90 | - | -$8.90 |
| Shares Outstanding | 58.4M | 57.2M | 55.9M | 55.0M | 60.4M | 69.3M | 68.4M | 58.2M | 42.2M | 42.2M | 37.1M | 31.2M | 3.6M | 3.4M | 3.0M |
| Operating Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | - | - | -268.2% | -384.0% | -3052.8% | -287.6% | -113.7% | -643.6% | -152.2% | -91.6% | -76.2% |
| Profit Margin | -764.0% | 1845.9% | -1312.6% | -1627.8% | - | - | -349.0% | -366.6% | -2994.6% | -284.0% | -115.2% | -636.1% | -154.3% | -80.1% | -108.6% |